hotspot -WSS

hotspot

author：comprehensive 2025-10-02 22:40:10 - browse：38859

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Adopting new red light myopia treatments may be short

WSS

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

A protest over insulin prices is seen as a fight for life

Stoke drug shows lower activity against childhood epilepsy

AI gets buy

Unique patient identifier: Experts argue the benefits, pitfalls

Updated Covid vaccine has 54% effectiveness, new study suggests

Wikipedia

hotspot

hotspot

Drug repurposing or repositioning? The language matters

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Affirmative action in medical school literally saved lives

Readout Newsletter: Amgen, Regeneron, BGI Group and more

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Interest rates are at a 22

Walensky prepares to leave CDC — and Congress — behind

A single Democrat is willing to weaken Medicare negotiation power

The high cost of giving birth even with insurance

VC firm RA Capital starts a new synthetic biology incubator

entertainment

Public health communication lessons from Covid

Why Novartis is going to walk from its acquisition of MorphoSys

Problems with a popular proposal to regulate AI in health care

Top private equity targets in 2023: cardiology, clinical trials, lasers

AI gets buy

Hospitals, health systems can help patients avoid medical debt

hotspot

focus

leisure time

entertainment